Biliary tract cancers (BTCs) are comprised of gallbladder carcinomas and cholangiocarcinomas. The prognosis of BTCs is poor and most patients present with unresectable disease. For patients with early stage BTCs, surgery is the treatment of choice. Adjuvant chemotherapy with or without radiation should be considered if there is lymph node positive disease or positive resection margins given the increased risk of recurrence. Gemcitabine or fluoropyrimidine-based chemotherapy is the standard of care for advanced BTCs. Liver-directed therapies can have a complementary role to chemotherapy in selected cases. Molecular distinctions amongst the different types of BTCs are coming to light, providing a rationale for the use of targeted therapies and clinical trial enrollment should be encouraged.

Original languageEnglish
Title of host publicationOncology
Number of pages10
ISBN (Electronic)9781119189596
ISBN (Print)9781119189558
StatePublished - 30 Aug 2019


  • Biliary tract cancer
  • Chemotherapy
  • Cholangiocarcinoma
  • Diagnosis
  • Gallbladder carcinoma
  • Surgery
  • Therapy


Dive into the research topics of 'Gallbladder/biliary duct cancers'. Together they form a unique fingerprint.

Cite this